Buy This $140 Billion Pharma Powerhouse Stock Now

Covid is on everyone’s mind, but biotech will keep being important even after the pandemic…

This story was originally published here.

Right now, everyone seems to be focusing on the race to develop a COVID-19 vaccine.

However, our other health problems … heart disease, cancer, respiratory diseases … haven’t gone away.

The Centers of Disease Control and Prevention estimates that more than 1 million Americans die from those three ailments alone every year.

Fortunately, there are pharmaceutical companies working hard throughout the pandemic to develop new treatments for a variety of health issues.

One of these companies is Bristol-Myers Squibb Co. (NYSE: BMY), headquartered in New York City.

The pharma giant received approval from the Food and Drug Administration (FDA) on May 15 to start selling a drug combination used to treat lung cancer.

And in March, the FDA approved BMY’s treatment for multiple sclerosis, a disease that afflicts nearly 1 million people in the U.S.

This is just the beginning, though. BMY has more than 50 new drugs in development as I write this.

That’s why I asked Brian Christopher to share his thoughts on what to expect going forward for this innovative company.

Editor's Note: To keep reading, click here.

Congress is about to decide on Blockchain

Right now, H.R. 1361 is gaining serious momentum in Congress – and for once, support is coming from both sides of the aisle.

The bill concerns a world-changing new technology expected to surge 77,400%.

The Economist hails this new technology as “the next big thing.” And Marc Andreessen — creator of the world’s first web browser — calls it “the most important technology since the internet itself.”

However, corporations are not waiting around for Congress to get its act together…

Companies such as Google, Overstock, Intel, Walmart, Nestle and Dole, to name a few, have already begun pumping billions into this technology.

And early investors stand to make huge profits as this brand-new industry could surge up to an expected 77,400%.

Indeed, it’s one of three massive technologies investors need to be tracking right now.

In short, we are at the crossroads of a potential $37 trillion financial event that could bring unthinkable wealth to investors who take action now.

Although this opportunity isn’t right for everyone – those who take advantage of it could turn a mere $50 investment into a small fortune.

Full details are revealed in this interview…